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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312S262Methods: A convenience sample of 28 individuals was studied. All
participants had to be 40 yr of age and meet the ACR deﬁnition for
knee OA. There was no requirement for minimum pain intensity and
management was to be continued as required. All participants were
asked to response to pings prompted from their smart phones and
subsequently rate their knee pain (0: no pain, 10: worst possible) three
times per day over 3months. Each of three daily pings was programmed
to occur at random in each of three 4-hour blocks (8am-noon, noon-
4pm, and 4pm-8pm). To characterize the statistical properties of the
time series of pain ratings, the means of the pain ratings in three blocks
were calculated and compared by one way analysis of covariance. As
well, fractal dimension, D, was calculated using rescaled range analysis
to characterize the OA participants’ pain ﬂuctuations.
Results: Thirty-two individuals participated in the study (18 females,
age (mean, standard deviation) 59.7 6.5 yr; 10 males, 55.36.7 yr). As
shown in Figure A, there is no signiﬁcant difference among the three
blocks of time for the mean rating of pain. Figure B displays the
distribution of fractal dimension, D. calculated for each individual's
mean daily pain intensity. The mean fractal dimension, D, for the
population is 1.650.04, which signiﬁes an anti- persistent pain time
series.
Conclusions: This is the ﬁrst analysis to characterize the fractal
dimension of OA pain. The ﬁnding of anti-persistent time series means
that on average more intense pain is followed by lesser pain, a ﬁnding
very similar to that reported for chronic low back pain and in contrast to
both purely neuropathic pain and acute pain. Whereas these previous
studies were over short time periods, this study suggests that power
law scaling can be preserved for much longer periods of time (weeks or
months), which is signiﬁcant for clinical application. The anti-persistent
pattern of pain is consistent with the concept of central pain processes
activated to modulate peripheral pain input in OA.
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Purpose: Pain is the most prominent and disabling symptom of oste-
oarthritis (OA). Thus, it is important to understand the cause of pain to
optimally treat this common disease. Pain in knee OA is involved in
a nociceptive pain, of which inﬂammation and the detrimental
mechanical stress to the joint are main cause. Recent studies have
shown that OA is associated with the signs and symptoms of inﬂam-
mation, and synovitis is common in OA. Serum levels of interleukin-6
(IL-6) and C-reactive protein (CRP) are reported to be associated with
synovitis and pain severity in knee OA. Walking analysis showed that
pain induced by detrimental mechanical stress due to the knee defor-
mity was positively correlated with pain severity only in advanced stage
of knee OA. However, it's still remained unclear which of these two
factors dominantly contribute to knee OA pain, or do their contributions
to knee OA pain may change according to the OA severity? This studywas conducted to answer these questions by obtaining data from knee
OA patients.
Methods: In this prospective cohort study, one-hundred sixty post-
menopausal women with knee OA, who had complained of knee pain
and provided written informed consent, were enrolled between Oct.
2009 and Dec. 2011. The severity of knee OA was classiﬁed by Kellgren-
Lawrence (K/L) grading scale based on standing extended-knee X-ray
images. Pain was evaluated by a visual analogue scale (VAS, 0-100) and
pain and stiffness sub-category of Japanese Knee Osteoarthritis
Measure (JKOM-pain), which is a patient-oriented outcomemeasure for
knee OA with sufﬁcient reliability and validity, similar to WOMAC and
SF-36. Serum levels of IL-6 and CRP were measured to monitor the
inﬂammation of knee OA. Anatomical axis angle (AAA) on standing
radiograph was measured as the objective indicator for mechanical
stress for lower limb. Univariate and multivariate analyses were con-
ducted to examine the relationships between the pain severities and
several clinical manifestations of knee OA patients.
Results:When a univariate analysis was conducted in all patients, there
was no signiﬁcant correlation between pain scores (pain VAS and
JKOM-pain) and the baseline characteristics, serum levels of IL-6 and
CRP, and radiographic OA severity, including in AAA. When the patients
were divided into two groups according to the radiographic severity of
knee OA, the early- (K/L2;67) and advanced-stage (K/L3 and 4; 93),
there was signiﬁcant positive correlation between serum IL-6 level and
both pain VAS score (r¼0.411, p¼0.001) and JKOM-pain score (r¼0.526,
p<0.001) in the early stage, while in advanced stage no signiﬁcant
correlations were found between these parameters. On the other hand,
there was signiﬁcant positive correlation between AAA and both pain
VAS score (r¼0.224, p¼0.033) and JKOM-pain score (r¼0.298, p¼0.004)
in the advanced stage, while in early stage no signiﬁcant correlations
were found between these parameters. Next, a multivariate analysis
was conducted to ﬁnd out the factors those can explain the pain severity
by loading of age, BMI, serum IL-6 level, serum hs-CRP level and AAA.
No factors were found to explain the pain severity when all patients
were included in the analysis. However, when the analysis was con-
ducted to the patients in early stage, only serum IL-6 level was signif-
icantly correlated with both the JKOM-pain score (b¼0.566,p<0.001)
and pain VAS score (b¼0.411,p¼0.002). When the analysis was con-
ducted to the patients in advanced stage, only AAA was signiﬁcantly
correlated with both the JKOM-pain score (b¼0.330, p¼0.004) and pain
VAS score (b¼0.240, p¼0.037).
Conclusions: The present study suggests that the components of knee
OA pain are changing dependent upon the progression of the disease;
the pain severity in knee OA patients is mainly affected by inﬂamma-
tion, probably synovitis, in early stage, while that of those by detri-
mental mechanical stress in advanced stage.
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Purpose: Sensitive, relevant and reliable measurements of pain levels
and their relationship to physical function are important for the
development of novel therapeutics for knee osteoarthritis (KOA). We
modiﬁed a previously-reported treadmill walking test protocol and
explored its capacity to measure analgesic efﬁcacy at baseline and
during paced walking. We hypothesized this would facilitate subject
enrollment and provide direct static and dynamic assessments of KOA
pain intensity and a response to acute treatment with conventional
doses of naproxen.
Methods: This was a randomized, double-blind, 3-period crossover
study performed at one site. Subjects with documented KOA were
screened to conﬁrm that their pain intensity (PI) scores were > 1 point
higher on an 11 point NRS scale after two weeks withdrawal of their
regularly prescribed NSAID. They thenwere randomized (1:1) to receive
different sequences of three 4-day courses of blinded capsules of BID
doses of 500mg naproxen (N) or placebo (P): N-P-P or P-N-N with 4 day
inter-period washouts. At each visit, the treadmill walking protocol
required four 20-min walks with 40 min rest periods. Subjects had one
predetermined self-paced (SP) walk prior to dosing on Day 4, then took
